Search Results - "COOK, R. J."

Refine Results
  1. 1

    The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020–2070) by Lang, J. C., Samant, S., Cook, J. R., Ranjan, S., Senese, F., Starnino, S., Giuffrida, S., Azzari, C., Baldo, V., Pawaskar, M.

    Published in Scientific reports (24-05-2024)
    “…Italy implemented two-dose universal varicella vaccination (UVV) regionally from 2003 to 2013 and nationally from 2017 onwards. Our objective was to analyze…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective, cohort study by Cook, JR, Jarvis, S, Knight, M, Dhanjal, MK

    “…Objective  To estimate the incidence of multiple repeat caesarean section (MRCS) (five or more) in the UK and to describe the outcomes for women and their…”
    Get full text
    Journal Article
  5. 5

    Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations by Jayaram, L, Pizzichini, M. M, Cook, R. J, Boulet, L-P, Lemiere, C, Pizzichini, E, Cartier, A, Hussack, P, Goldsmith, C. H, Laviolette, M, Parameswaran, K, Hargreave, F. E

    Published in The European respiratory journal (01-03-2006)
    “…One important goal of asthma treatment is to reduce exacerbations. The current authors investigated if the use of sputum cell counts to guide treatment would…”
    Get full text
    Journal Article
  6. 6

    Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome by Yip, Connie, Dinkel, Charlotte, Mahajan, Abhishek, Siddique, Musib, Cook, Gary J. R., Goh, Vicky

    Published in Insights into imaging (01-08-2015)
    “…In recent years, there has been increasing interest in the influence of body composition on oncological patient outcomes. Visceral obesity, sarcopenia and…”
    Get full text
    Journal Article
  7. 7

    Molecular imaging of hypoxia in non-small-cell lung cancer by Yip, Connie, Blower, Philip J., Goh, Vicky, Landau, David B., Cook, Gary J. R.

    “…Non-small-cell lung cancer (NSCLC) is the commonest cancer worldwide but survival remains poor with a high risk of relapse, particularly after nonsurgical…”
    Get full text
    Journal Article
  8. 8

    Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease by Terpos, E, Berenson, J, Cook, R J, Lipton, A, Coleman, R E

    Published in Leukemia (01-05-2010)
    “…Skeletal-related events (SREs) are common in patients with osteolytic lesions from multiple myeloma (MM), and result in substantial morbidity. We report herein…”
    Get full text
    Journal Article
  9. 9

    Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer by Hughes, Daniel Johnathan, Chand, Gitasha, Johnson, Jessica, Bailey, Damion, Adamson, Kathryn, Goh, Vicky, Cook, Gary J. R.

    Published in EJNMMI research (31-05-2023)
    “…Background Immune checkpoint inhibitors, including those against programmed cell death protein-1 (PD-1) or its ligand (PD-L1), are routinely used to treat…”
    Get full text
    Journal Article
  10. 10

    Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial by Sim, Ie-Wen, Borromeo, Gelsomina L, Tsao, Claudine, Hardiman, Rita, Hofman, Michael S, Papatziamos Hjelle, Christian, Siddique, Musib, Cook, Gary J R, Seymour, John F, Ebeling, Peter R

    Published in Journal of clinical oncology (10-09-2020)
    “…Medication-related osteonecrosis of the jaw (MRONJ) is an infrequent but morbid and potentially serious condition associated with antiresorptive and…”
    Get full text
    Journal Article
  11. 11

    Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT by O’Shea, Robert J., Rookyard, Chris, Withey, Sam, Cook, Gary J. R., Tsoka, Sophia, Goh, Vicky

    Published in Insights into imaging (17-06-2022)
    “…Objectives Radiomic models present an avenue to improve oesophageal adenocarcinoma assessment through quantitative medical image analysis. However, model…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes by Cook, J.R., Carta, L., Galatioto, J., Ramirez, F.

    Published in Clinical genetics (01-01-2015)
    “…Cardiovascular abnormalities are the major cause of morbidity and mortality in Marfan syndrome (MFS) and a few clinically related diseases that share, with…”
    Get full text
    Journal Article
  14. 14

    Group O RBCs: where is universal donor blood being used by Barty, R. L., Pai, M., Liu, Y., Arnold, D. M., Cook, R. J., Zeller, M. P., Heddle, N. M.

    Published in Vox sanguinis (01-05-2017)
    “…Background There have been recurrent shortages of group O blood due to insufficient inventory and use of group O blood in ABO non‐identical recipients. We…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma by Olin, R L, Vogl, D T, Porter, D L, Luger, S M, Schuster, S J, Tsai, D E, Siegel, D L, Cook, R J, Mangan, P A, Cunningham, K, Stadtmauer, E A

    Published in Bone marrow transplantation (Basingstoke) (01-03-2009)
    “…Therapeutic options for patients with multiple myeloma whose disease has relapsed after a prior auto-SCT include novel biologic therapies, traditional…”
    Get full text
    Journal Article
  17. 17

    Standardisation of conventional and advanced iterative reconstruction methods for Gallium-68 multi-centre PET-CT trials by Krokos, Georgios, Pike, Lucy C., Cook, Gary J. R., Marsden, Paul K.

    Published in EJNMMI physics (17-07-2021)
    “…Purpose To assess the applicability of the Fluorine-18 performance specifications defined by EANM Research Ltd (EARL), in Gallium-68 multi-centre PET-CT trials…”
    Get full text
    Journal Article
  18. 18

    [99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression by Nazir, Muhummad Sohaib, Hughes, Daniel Johnathan, Chand, Gitasha, Adamson, Kathryn, Johnson, Jessica, Bailey, Damion, Gibson, Victoria, Ting, Hong Hoi, Lyon, Alexander R., Cook, Gary J. R.

    Published in EJNMMI research (17-05-2023)
    “…Background Myocardial programmed death-ligand 1 (PD-L1) expression is implicated in immune checkpoint inhibitor (ICI)-associated myocarditis. Measurement of…”
    Get full text
    Journal Article
  19. 19

    Statistical methods for incomplete data: Some results on model misspecification by McIsaac, Michael, Cook, RJ

    Published in Statistical methods in medical research (01-02-2017)
    “…Inverse probability weighted estimating equations and multiple imputation are two of the most studied frameworks for dealing with incomplete data in clinical…”
    Get full text
    Journal Article
  20. 20

    Optimisation of CT protocols in PET-CT across different scanner models using different automatic exposure control methods and iterative reconstruction algorithms by Gould, Sarah-May, Mackewn, Jane, Chicklore, Sugama, Cook, Gary J. R., Mallia, Andrew, Pike, Lucy

    Published in EJNMMI physics (31-07-2021)
    “…Background A significant proportion of the radiation dose from a PET-CT examination is dependent on the CT protocol, which should be optimised for clinical…”
    Get full text
    Journal Article